decisionhealth Newsletters, Part B News - 2021 Issue 2 (February)
AMA announces new CPT code for Johnson & Johnson’s COVID-19 vaccine
Subscribe or sign in to view the full article.
Article Overview
This article explains a coding update from the AMA related to a COVID-19 vaccine candidate under development by Janssen Pharmaceuticals, a division of Johnson & Johnson. It is relevant to coders, billing staff, and reimbursement professionals tracking vaccine code updates, associated administration coding, and timing tied to regulatory authorization.
Why This Topic Matters
The article helps readers stay current on new vaccine-related coding changes and understand when the newly added codes are expected to become effective. This matters for organizations that track AMA, CPT, HCPCS Level II, and federal vaccine coding updates.
Article Sections
-
Coding
Introduces the coding update and the context for the newly added vaccine-related codes. It also notes the federal approval or authorization timing tied to effectiveness.
What You Will Learn
- How the AMA announced a new vaccine-related coding update
- What general type of vaccine coding change was made
- Which organizations and regulatory context are associated with the update
- How the article frames the timing of code effectiveness
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle professionals
- Compliance teams
- Healthcare administrators
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com